Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells
European Journal of Nutrition · 2025
DOI: 10.1007/s00394-024-03507-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nutrition, 2025. Verfasst von Kathrin Hedegger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU München, Feodor-Lynen-Straße 25, 81377, Munich, Germany. Hauptthemen laut MEDLINE: Interleukin-6, Infant Formula, Toll-Like Receptor 9, Intestinal Mucosa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Veterinary Medicine Vienna.
Abstract (Originalsprache)
Purpose
Necrotizing enterocolitis (NEC) is the most severe gastrointestinal disease in preterm infants caused by an exaggerated intestinal epithelial immune activation. Several studies show that modulation of toll-like receptor 9 (TLR9) activity may have positive effects on preventing intestinal inflammatory mechanisms ultimately resulting in NEC development. In this study, the effect of various infant formulas (IF) and the probiotic strain Limosilactobacillus fermentum CECT5716 on TLR9 activation were analyzed in vitro.
Methods
First, TLR4 and TLR9 expression was analyzed on human primary intestinal epithelial cells (P-IECs) by qPCR and Western blot analysis. Then genetically designed HEK-Dual™ hTLR9 (NF/IL8) reporter cells (HEK-Dual) were treated with different IFs, L. fermentum CECT5716, and different functional components to measure TLR9 activation via luminescence. Finally, the IFs were investigated in P-IECs to analyze TLR downstream signaling by Western blot analysis.
Results
IFs containing intact protein and L. fermentum CECT5716 activated TLR9 in HEK-Dual cells, but the functional components lactoferrin, L-5-methyltetrahydrofolate, and hydrolyzed whey proteins failed to activate TLR9. In P-IECs, the IFs induced increased phosphorylation of MAPK8/9 of the TLR signaling pathway and significantly reduced IL6 levels. Consistently, IL6 levels were increased in P-IECs when TLR9-signaling was inhibited. Interestingly, L. fermentum CECT5716 enhanced TLR9-signaling and increased NF-kappa-B inhibitor alpha-phosphorylation.
Conclusion
We found out that the used control formula, prebiotic formula, prebiotic formula with hydrolyzed-protein, and L. fermentum CECT5716 reduce IL6 levels in human P-IECs through TLR9 activation. L. fermentum CECT5716 and the here tested IFs could be a promising approach for modulation of gut health in infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU München, Feodor-Lynen-Straße 25, 81377, Munich, Germany.
- Institute of in vivo and in vitro Models, University of Veterinary Medicine Vienna, Veterinärplatz 1, 1210, Vienna, Austria.
- HiPP GmbH & Co. Vertrieb KG, Georg-Hipp-Straße 7, 85276, Pfaffenhofen, Germany.
- Institute of in vivo and in vitro Models, University of Veterinary Medicine Vienna, Veterinärplatz 1, 1210, Vienna, Austria. Maik.Dahlhoff@vetmeduni.ac.at.
Förderung
- University of Veterinary Medicine Vienna
Zitieren
APA
Hedegger, K., Hommel, T., Schaubeck, M., Gimpfl, M., & Dahlhoff, M. (2025). Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells. European Journal of Nutrition. https://doi.org/10.1007/s00394-024-03507-7
Vancouver
Hedegger K, Hommel T, Schaubeck M, Gimpfl M, Dahlhoff M. Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells. European Journal of Nutrition. 2025. doi:10.1007/s00394-024-03507-7
BibTeX
@article{Hedegger2025,
author = {Hedegger, Kathrin and Hommel, Theresa and Schaubeck, Monika and Gimpfl, Martina and Dahlhoff, Maik},
title = {Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells},
journal = {European Journal of Nutrition},
year = {2025},
doi = {10.1007/s00394-024-03507-7}
}
EUVIMED